Latest filing published 26 Jun 2026 for Arvinas, INC.. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Briggs Morrison has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Syndax Pharmaceuticals Inc, Arvinas, Inc. and Sesen Bio, Inc. Over a trading history stretching from 17 September 2021 to 24 June 2026, the count stands at 24 filings.
On the open market, the record shows 2 purchases worth €423k and 1 sale worth €95k. Taken together, the purchases exceed the sales by €329k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants and 15 option exercises. 2026 to date brings 1 purchase and no sales.
The latest filing, published on 26 June 2026, reports a share grant in Arvinas, Inc. The latest purchase dates back some time: it was published 223 days ago, on 9 March 2026. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations